105 results about "Allergic purpura" patented technology

The invention discloses a Chinese medicinal composition for treating allergic purpura. The composition comprises the following components in percentage by mass: 5.1 to 7.1 percent of argy wormwood leaves, 5.1 to 7.1 percent of dark plum fruit, 5.1 to 7.1 percent of donkey-hide glue, 5.1 to 7.1 percent of Chinese angelica, 5.1 to 7.1 percent of honeysuckle flower, 5.1 to 7.1 percent of sophora flower, 5.1 to 7.1 percent of liquorice root, 2 to 4 percent of rhubarb, 7.4 to 9.4 percent of radix rehmanniae, 5.1 to 7.1 percent of redroot gromwell root, 5.1 to 7.1 percent of moutan bark of tree peony, and 33 to 35 percent of Chinese date, wherein the total content of the components is 100 percent; and the components are decocted with water. The Chinese medicinal composition has the characteristics of quick response, good curative effect, complete treatment and relapse prevention.

The invention provides a Chinese medicinal composition for treating anaphylactoid purpura and thrombocytopenic purpura. The Chinese medicinal composition comprises the following raw materials or extracts thereof: rehmannia root, rehmannia root, stir-fried white paeony root, raw sanguisorba root, hairyvein agrimonia herb and bud, patience dock root, Sinkiang arnebia root, indigowoad leaf, weeping forsythia, herba ecliptae, giant knotweed rhizome, cicada slough, densefruit pittany root-bark, raw cattail pollen, peanut coat, tea begonia and Phnom Penh malus spectabilis. The Chinese medicinal composition for treating the anaphylactoid purpura and the thrombocytopenic purpura is quick in effectiveness, definite in a curative effect and free from toxic and side effects, and the anaphylactoid purpura and the thrombocytopenic purpura are difficult to relapse.

The invention relates to the field of medicament formulas, in particular to sinkiang arnebia root-honeysuckle flower-red paeony root-Chinese arborvitae twig soup for treating allergic purpura. The soup is characterized by consisting of the following bulk pharmaceuticals in percentage by weight: 5-8 percent of inkiang arnebia root, 8-11 percent of honeysuckle flower, 7-9 percent of red paeony root, 5-7 percent of Chinese arborvitae twig, 5-7 percent of tree peony bark, 4-6 percent of crude rehmannia, 4-6 percent of fineleaf schizonepeta herb, 3-6 percent of divaricate saposhnikovia root, 3-6 percent of figwort, 5-7 percent of dwarf lilyturf root, 3-5 percent of Chinese atractylodes, 8-11 percent of cogongrass rhizome, 4-7 percent of red-rooted salvia root, 2-4 percent of liquoric root, 2-4 percent of pseudo-ginseng root powder, 6-9 percent of paniculate swallowwort root and 4-7 percent of lightyellow sophora root. A preparation method of the soup comprises the following steps of: packaging pseudo-ginseng root powder separately; soaking the other 16 types of bulk pharmaceuticals into water and decocting; and removing residues to obtain a filtrate, and adding pseudo-ginseng root powder to obtain sinkiang arnebia root-honeysuckle flower-red paeony root-Chinese arborvitae twig soup. The soup is low in cost, has a good curative effect on allergic purpura, is free from toxic and side effects, has the effects of detoxifying, promoting eruption, clearing heat, removing ecchymoses, cooling wind-heat, cooling blood, arresting bleeding and the like, and is suitable for simple type, joint type, abdominal type, kidney type and mixed type allergic purpura.

The invention provides a traditional Chinese herbal composition for treating allergic purpura and a method for preparing the same. The traditional Chinese herbal composition is prepared from 8 active pharmaceutical ingredients of suberect spatholobus stem, eclipta alba, leonurus, lithospermum, common ducksmeat herb, cortex dictamni, mulberry bark and schizonepeta according to a certain weight ratio. The traditional Chinese herbal composition has a good curative effect on allergic purpura.

The invention discloses a traditional Chinese medicine composition for treating allergic purpura, which is prepared from the following raw materials in parts by weight: 18-20 parts of honeysuckle, 4-6 parts of radix rehmanniae recen, 1-3 parts of atractylodes macrocephala, 5-7 parts of lithospermum, 8-10 parts of periostracum cicadae, 2-4 parts of radix cyathulae, 6-8 parts of tree peony bark, 4-5 parts of mint leaf, 2-4 parts of grossy privet fruit, 6-8 parts of alisma, 4-5 parts of radix saposhnikoviae, 1-3 parts of carbonized sanguisorba root, 5-6 parts of lalang grass rhizome, 2-4 parts of prepared fleece-flower root, 1-3 parts of black sesame, 6-8 parts of herba violae, 2-4 parts of broomjute sida root and 1-3 parts of erose mussaenda leaf. The traditional Chinese medicine composition is prepared from natural medicines and has a definite curative effect and can effectively treat allergic purpura; the medicines cooperate to achieve the efficacies of nourishing blood, activating blood circulation, cooling blood, removing toxicity, adjusting immunity, permeating to remove ecchymosis, dispelling wind-evil and relieving itching. The traditional Chinese medicine composition can treat allergic purpura quickly and effectively, has no toxic or side effect and can avoid recurrence after curing.

The invention relates to application of pharmaceutically-acceptable forms and derivatives of oxymatrines(oxymatrine, matrine and iosmatrine) to prepare medicines treating skin vasculitis (such as allergic cutaneous vasculitis, allergic purpura, erythema elevatum diutinum, acute febrile neutrophilic dermatosis, urticarial vasculitis, pustular vasculitis, polyarteritis nodosa, gnagrenous pyoderma, eosinophilic vasculitis, eosinophilic cellulitis, pigmented purpuric dermatoses, wegner granulomatosis, behcet disease, erythema nodosum, and erythema induratum).

The invention provides application of a buffalo horn rehmannia root medicinal composition in preparing a medicament for preventing and treating related rash caused by an epidermal growth factor receptor inhibitor. The buffalo horn rehmannia root medicinal composition comprises buffalo horn, peony roots, rehmannia roots and tree peony root bark as effective components. The invention creatively usesthe medicinal composition of the buffalo horn rehmannia root decoction used for severe hepatitis, hepatic coma, uremia, allergic purpura acute leukemia, septicemia and other diseases to prevent and treat the rash caused by the epidermal growth factor receptor inhibitor. The composition has good clinical curative effect and low toxicity, and can be taken for a long time.